Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 137

1.

Inhibition of human tumour prostate PC-3 cell growth by cannabinoids R(+)-Methanandamide and JWH-015: involvement of CB2.

Olea-Herrero N, Vara D, Malagarie-Cazenave S, Díaz-Laviada I.

Br J Cancer. 2009 Sep 15;101(6):940-50. doi: 10.1038/sj.bjc.6605248. Epub 2009 Aug 18.

2.

The cannabinoid R+ methanandamide induces IL-6 secretion by prostate cancer PC3 cells.

Olea-Herrero N, Vara D, Malagarie-Cazenave S, Díaz-Laviada I.

J Immunotoxicol. 2009 Dec;6(4):249-56. doi: 10.3109/15476910903241696.

PMID:
19908944
3.
4.

Cannabinoid receptor activation induces apoptosis through tumor necrosis factor alpha-mediated ceramide de novo synthesis in colon cancer cells.

Cianchi F, Papucci L, Schiavone N, Lulli M, Magnelli L, Vinci MC, Messerini L, Manera C, Ronconi E, Romagnani P, Donnini M, Perigli G, Trallori G, Tanganelli E, Capaccioli S, Masini E.

Clin Cancer Res. 2008 Dec 1;14(23):7691-700. doi: 10.1158/1078-0432.CCR-08-0799.

5.

Inhibition of glioma growth in vivo by selective activation of the CB(2) cannabinoid receptor.

Sánchez C, de Ceballos ML, Gomez del Pulgar T, Rueda D, Corbacho C, Velasco G, Galve-Roperh I, Huffman JW, Ramón y Cajal S, Guzmán M.

Cancer Res. 2001 Aug 1;61(15):5784-9.

6.

Anti-proliferative and anti-angiogenic effects of CB2R agonist (JWH-133) in non-small lung cancer cells (A549) and human umbilical vein endothelial cells: an in vitro investigation.

Vidinský B, Gál P, Pilátová M, Vidová Z, Solár P, Varinská L, Ivanová L, Mojžíš J.

Folia Biol (Praha). 2012;58(2):75-80.

7.

Cannabinoids induce apoptosis of pancreatic tumor cells via endoplasmic reticulum stress-related genes.

Carracedo A, Gironella M, Lorente M, Garcia S, Guzmán M, Velasco G, Iovanna JL.

Cancer Res. 2006 Jul 1;66(13):6748-55.

8.
10.

Spisulosine (ES-285) induces prostate tumor PC-3 and LNCaP cell death by de novo synthesis of ceramide and PKCzeta activation.

Sánchez AM, Malagarie-Cazenave S, Olea N, Vara D, Cuevas C, Díaz-Laviada I.

Eur J Pharmacol. 2008 Apr 28;584(2-3):237-45. doi: 10.1016/j.ejphar.2008.02.011. Epub 2008 Feb 14.

PMID:
18343365
11.
12.

Cannabinoid receptor 2 agonist ameliorates mesenteric angiogenesis and portosystemic collaterals in cirrhotic rats.

Huang HC, Wang SS, Hsin IF, Chang CC, Lee FY, Lin HC, Chuang CL, Lee JY, Hsieh HG, Lee SD.

Hepatology. 2012 Jul;56(1):248-58. doi: 10.1002/hep.25625. Epub 2012 Jun 6.

PMID:
22290687
14.

The CB(1) cannabinoid receptor is coupled to the activation of c-Jun N-terminal kinase.

Rueda D, Galve-Roperh I, Haro A, Guzmán M.

Mol Pharmacol. 2000 Oct;58(4):814-20.

15.

Small molecule tolfenamic acid inhibits PC-3 cell proliferation and invasion in vitro, and tumor growth in orthotopic mouse model for prostate cancer.

Sankpal UT, Abdelrahim M, Connelly SF, Lee CM, Madero-Visbal R, Colon J, Smith J, Safe S, Maliakal P, Basha R.

Prostate. 2012 Nov;72(15):1648-58. doi: 10.1002/pros.22518. Epub 2012 Apr 2.

PMID:
22473873
16.

CB2 cannabinoid receptor agonist JWH-015 modulates human monocyte migration through defined intracellular signaling pathways.

Montecucco F, Burger F, Mach F, Steffens S.

Am J Physiol Heart Circ Physiol. 2008 Mar;294(3):H1145-55. doi: 10.1152/ajpheart.01328.2007. Epub 2008 Jan 4.

PMID:
18178718
17.

Synthetic cannabinoid receptor agonists inhibit tumor growth and metastasis of breast cancer.

Qamri Z, Preet A, Nasser MW, Bass CE, Leone G, Barsky SH, Ganju RK.

Mol Cancer Ther. 2009 Nov;8(11):3117-29. doi: 10.1158/1535-7163.MCT-09-0448. Epub 2009 Nov 3.

18.

Non-THC cannabinoids inhibit prostate carcinoma growth in vitro and in vivo: pro-apoptotic effects and underlying mechanisms.

De Petrocellis L, Ligresti A, Schiano Moriello A, Iappelli M, Verde R, Stott CG, Cristino L, Orlando P, Di Marzo V.

Br J Pharmacol. 2013 Jan;168(1):79-102. doi: 10.1111/j.1476-5381.2012.02027.x.

19.

Activation of cannabinoid 2 receptors protects against cerebral ischemia by inhibiting neutrophil recruitment.

Murikinati S, Jüttler E, Keinert T, Ridder DA, Muhammad S, Waibler Z, Ledent C, Zimmer A, Kalinke U, Schwaninger M.

FASEB J. 2010 Mar;24(3):788-98. doi: 10.1096/fj.09-141275. Epub 2009 Nov 2.

PMID:
19884325
20.

Protoapigenone, a novel flavonoid, induces apoptosis in human prostate cancer cells through activation of p38 mitogen-activated protein kinase and c-Jun NH2-terminal kinase 1/2.

Chang HL, Wu YC, Su JH, Yeh YT, Yuan SS.

J Pharmacol Exp Ther. 2008 Jun;325(3):841-9. doi: 10.1124/jpet.107.135442. Epub 2008 Mar 12.

Supplemental Content

Support Center